Safety and efficacy of first-line bevacizumab combination therapy in Chinese population with advanced non-squamous NSCLC: data of subgroup analyses from MO19390 (SAiL) study
贝伐单抗
医学
内科学
肿瘤科
人口
化疗
环境卫生
作者
C.Z. Zhou,Chunxue Bai,Zhong Zhen Guan,Guangliang Jiang,Yuankai Shi,M. Z. Wang,Yi‐Long Wu,Y. P. Zhang,Yixiang Zhu